TRACON PHARMACEUTICALS I (TCON)
Institutional ownership reported to the SEC as of Q3 2024, across 24 quarters.
1
Reporting holders
$5
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Game Plan Financial Advisors, LLC | $5 | 50 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 1 | $5 | 50 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 1 | $80 | 50 | 1 | 0 | 0 | 0.0% |
| Q1 2024 | 24 | $1.1M | 2,466,943 | 9 | 2 | 3 | 0.0% |
| Q4 2023 | 20 | $814.5K | 4,651,361 | 6 | 1 | 3 | 0.0% |
| Q3 2023 | 18 | $1.6M | 9,178,296 | 2 | 2 | 1 | 0.0% |
| Q2 2023 | 22 | $2.8M | 9,738,922 | 1 | 3 | 3 | 0.4% |
| Q1 2023 | 27 | $18.5M | 9,747,011 | 3 | 5 | 3 | 0.7% |
| Q4 2022 | 25 | $13.9M | 9,278,429 | 6 | 2 | 6 | 0.5% |
| Q3 2022 | 33 | $16.5M | 9,862,225 | 1 | 4 | 6 | 0.3% |
| Q2 2022 | 33 | $19.9M | 9,871,108 | 2 | 6 | 8 | 0.9% |
| Q1 2022 | 36 | $24.8M | 9,131,177 | 6 | 10 | 8 | 3.3% |
| Q4 2021 | 35 | $26.7M | 9,179,385 | 3 | 8 | 9 | 4.8% |
| Q3 2021 | 45 | $40.2M | 10,231,356 | 7 | 11 | 9 | 1.6% |
| Q2 2021 | 46 | $58.9M | 9,016,395 | 6 | 6 | 15 | 0.6% |
| Q1 2021 | 42 | $73.4M | 8,845,710 | 12 | 11 | 9 | 0.8% |
| Q4 2020 | 39 | $99.4M | 8,485,250 | 18 | 12 | 4 | 0.1% |
| Q3 2020 | 26 | $29.7M | 5,749,655 | 13 | 3 | 4 | 0.0% |
| Q2 2020 | 18 | $3.0M | 1,553,892 | 3 | 7 | 1 | 0.0% |
| Q1 2020 | 18 | $2.1M | 1,267,052 | 9 | 2 | 3 | 0.0% |
| Q4 2019 | 14 | $2.8M | 1,199,800 | 11 | 0 | 2 | 0.0% |
| Q3 2019 | 21 | $7.6M | 16,936,678 | 1 | 6 | 4 | 0.0% |
| Q2 2019 | 24 | $11.7M | 17,155,338 | 6 | 4 | 4 | 0.0% |
| Q1 2019 | 23 | $23.2M | 16,908,757 | 4 | 5 | 4 | 0.0% |
| Q4 2018 | 26 | $11.0M | 17,411,503 | 2 | 0 | 0 | 0.0% |